Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Non-Current Assets (2016 - 2025)

Immucell (ICCC) has disclosed Non-Current Assets for 16 consecutive years, with $28.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-Current Assets fell 5.42% year-over-year to $28.9 million, compared with a TTM value of $118.2 million through Sep 2025, down 5.9%, and an annual FY2024 reading of $30.1 million, down 7.05% over the prior year.
  • Non-Current Assets was $28.9 million for Q3 2025 at Immucell, down from $29.6 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $33.1 million in Q2 2023 and bottomed at $27.8 million in Q1 2021.
  • Average Non-Current Assets over 5 years is $30.0 million, with a median of $30.0 million recorded in 2022.
  • The sharpest move saw Non-Current Assets grew 15.38% in 2023, then dropped 7.05% in 2024.
  • Year by year, Non-Current Assets stood at $28.2 million in 2021, then increased by 9.45% to $30.9 million in 2022, then rose by 4.77% to $32.3 million in 2023, then fell by 7.05% to $30.1 million in 2024, then decreased by 3.84% to $28.9 million in 2025.
  • Business Quant data shows Non-Current Assets for ICCC at $28.9 million in Q3 2025, $29.6 million in Q2 2025, and $29.7 million in Q1 2025.